CRDL
Cardiol Therapeutics
CRDL
CRDL
46 hedge funds and large institutions have $37.5M invested in Cardiol Therapeutics in 2026 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
12% more funds holding
Funds holding: 41 → 46 (+5)
Holders
46
Holding in Top 10
1
Calls
$222K
Puts
–
Top Buyers
| 1 | +$15.5M | |
| 2 | +$2.8M | |
| 3 | +$841K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$816K |
| 5 |
Renaissance Technologies
New York
|
+$236K |
Top Sellers
| 1 | -$570K | |
| 2 | -$350K | |
| 3 | -$144K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$137K |
| 5 |
Morgan Stanley
New York
|
-$96.5K |
